The motion preservation device market is the fastest growing segment within the U.S. spinal implant market, with DePuy Synthes leading the growth, according to an iData Research report.
Spinal Tech
NuVasive elected Vickie L. Capps to the board of directors.
The first patient is enrolled in a new major multicentric clinical protocol designed to study the medical value of the Jazz Band treatment for instrumented thoracic and lumbar arthrodesis.
InVivo Therapeutics appointed Ann Merrifield lead director of the company's board of directors.
Seeking Alpha released a new report on the orthobiologics market, which has experienced tremendous growth over the past 20 years.
Advertisement
Invuity began trading on June 15 on the NASDAQ Global Market.
Aesculap Implant Systems received FDA approval for the activL Artificial Disc.
Vericel plans to submit a biologics license application to the FDA by the end of 2015 for MACI, a new biologic.
FH Ortho received approval from the FDA to market its CALCAnail System.
Fifty young patients have now undergone scoliosis treatment with the ApiFix system.